Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Kobayashi Pharmaceutical Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	13,914	27,559	27,950	27,636	26,635
Depreciation & Amortization	8,022	6,057	5,358	4,835	4,106
Loss (Gain) From Sale of Assets	50	118	121	378	1,186
Loss (Gain) From Sale of Investments	-635	-436	89	-84	-261
Other Operating Activities	-7,493	-8,359	-8,007	-8,396	-7,900
Change in Accounts Receivable	4,780	-3,781	8,296	-1,523	1,588
Change in Inventory	-1,144	-3,175	-1,977	-462	1,309
Change in Accounts Payable	-9,447	361	515	-158	-4,178
Change in Other Net Operating Assets	3,199	16	-431	193	1,501
Operating Cash Flow	11,246	18,360	31,914	22,419	23,986
Operating Cash Flow Growth	-38.75%	-42.47%	42.35%	-6.53%	19.40%
Capital Expenditures	-26,056	-12,756	-14,747	-3,663	-3,795
Sale of Property, Plant & Equipment	22	5	3	10	15
Cash Acquisitions	-	-11,176	-	-	-11,355
Divestitures	-	-	-	200	-
Sale (Purchase) of Intangibles	-573	-813	-1,482	-522	-354
Investment in Securities	8,053	5,395	2,168	12,095	2,838
Other Investing Activities	139	-231	-254	-129	-5
Investing Cash Flow	-18,415	-19,576	-14,312	7,991	-12,656
Short-Term Debt Repaid	-	-	-1	-12	-5
Total Debt Repaid	-	-	-1	-12	-5
Net Debt Issued (Repaid)	-	-	-1	-12	-5
Repurchase of Common Stock	-	-12,000	-14,056	-3,943	-
Dividends Paid	-7,505	-7,223	-6,509	-6,251	-5,784
Other Financing Activities	-263	-240	-193	-171	-230
Financing Cash Flow	-7,768	-19,463	-20,759	-10,377	-6,019
Foreign Exchange Rate Adjustments	1,220	890	673	797	-425
Miscellaneous Cash Flow Adjustments	-	-	-22	-	-2
Net Cash Flow	-13,717	-19,789	-2,506	20,830	4,884
Free Cash Flow	-14,810	5,604	17,167	18,756	20,191
Free Cash Flow Growth	-	-67.36%	-8.47%	-7.11%	28.52%
Free Cash Flow Margin	-8.94%	3.23%	10.33%	12.08%	13.41%
Free Cash Flow Per Share	-199.22	73.89	222.57	240.08	258.32
Cash Interest Paid	34	22	18	17	15
Cash Income Tax Paid	7,471	8,358	8,003	8,464	7,972
Levered Free Cash Flow	-13,061	2,535	11,183	14,511	15,043
Unlevered Free Cash Flow	-13,043	2,553	11,194	14,522	15,056
Change in Working Capital	-2,612	-6,579	6,403	-1,950	220

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.